Reta Lila Weston Trust For Medical Research

Quick Stats

• Annual Giving: £740,000 (2023-24 charitable expenditure)
• Success Rate: Not applicable (invitation only)
• Decision Time: Not disclosed
• Grant Range: £750,000 - £5,100,000
• Geographic Focus: UK-wide, with strong UCL focus

Contact Details

Address: The Trust Partnership Ltd, 6 Trull Farm Buildings, Trull, Tetbury, Gloucestershire GL8 8SQ

Charity Number: 256279

Note: The Trust does not have publicly available phone or email contact details for unsolicited enquiries.

Overview

The Reta Lila Weston Trust for Medical Research is a private UK family trust established in the 1970s (formally constituted 1968) to fund neurological medical research. With total income of £706,622 and charitable expenditure of £738,647 in 2023-24, the Trust maintains a significant investment portfolio (generating £7.2 million in investment gains in 2023-24) to support long-term strategic funding. The Trust's founding mission was to establish and fund the Reta Lila Weston Institute of Neurological Studies at University College London, which remains a core beneficiary after more than 50 years of partnership. The Trust operates through trustee discretion rather than open applications, making strategic, high-value grants to select UK research institutions working on neurodegenerative conditions including Parkinson's Disease, Motor Neurone Disease, Lewy body dementia, and progressive supranuclear palsy.

Funding Priorities

Grant Programs

The Trust does not operate formal grant programs with published application rounds. Instead, it makes strategic awards through trustee discretion:

• Major Strategic Grants: £750,000 - £5,100,000 for multi-year research projects at leading neurology centres
• Institutional Support: Ongoing funding to the Reta Lila Weston Institute at UCL
• Thematic Initiatives: Launched specific funding streams (e.g., 2016 Microbiome Funding initiative worth £1.2 million)

Priority Areas

The Trust funds research into:

• Neurodegenerative Diseases: Parkinson's Disease, Motor Neurone Disease/ALS, Lewy body dementia, progressive supranuclear palsy (PSP), Alzheimer's disease
• Microbiome Research: Investigating gut-brain axis in neurological conditions
• AI and Technology: Advanced analytical platforms for brain tissue research and biomarker discovery
• Clinical Trials: Translational research bridging laboratory findings to patient care
• Neonatal Neurology: Impact of microbiota on neonatal mortality
• Developmental Neuroscience: Effects of childhood trauma on brain development in vulnerable adolescents

What They Don't Fund

Based on their documented grants, the Trust does not fund:

• Research outside neurological/neurodegenerative diseases
• Non-UK institutions (all documented grants are to UK research centres)
• Non-research activities (service delivery, equipment outside research context, general running costs)

Ready to write a winning application for Reta Lila Weston Trust For Medical Research?

Our AI helps you craft proposals that match their exact priorities. Save hours and increase your success rate.

Learn more >

Governance and Leadership

The Trust uses a corporate trustee structure (1 trustee listed on Charity Commission register). No trustees receive remuneration, payments, or benefits from the charity. The Trust is administered through The Trust Partnership Ltd based in Gloucestershire. The Trust maintains a low public profile with minimal public communications about governance or decision-making processes.

How to Apply to Reta Lila Weston Trust For Medical Research

How to Apply

This funder does not have a public application process. The Trust operates as a private family trust making grants through trustee discretion. All documented grants appear to be awarded through:

• Pre-existing relationships with leading UK neurology research institutions
• Trustee-initiated funding calls on specific themes (e.g., the 2016 Microbiome initiative)
• Invitation to specific research teams or institutions
• Long-term strategic partnerships (particularly with UCL)

The Charity Commission register notes that “this charity only provides its support via other charities,” indicating grants are made to registered charitable institutions rather than individuals.

Decision Timeline

Not disclosed. Given the size of grants (£750,000 - £5.1 million), decisions likely involve extended due diligence processes.

Success Rates

Not applicable - no public application process.

Reapplication Policy

Not applicable - no public application process.

Application Success Factors

Since there is no public application process, traditional “application success factors” do not apply. However, examining the Trust's documented funding reveals clear patterns:

Institutions Funded:

• University College London (multiple grants including £5.1 million in 2025 for AI brain tissue platform)
• University of Edinburgh (£750,000 for Parkinson's probiotic research, 2021)
• National Hospital for Neurology and Neurosurgery, London (£1.2 million for MND microbiome research, 2016)

Common Characteristics of Funded Projects:

• World-class research teams: All funded projects involve leading neurologists and neuroscientists
• Translational focus: Projects bridge basic science and clinical application (e.g., Edinburgh project combining worm/mouse models with clinical trials)
• Innovation: Use of cutting-edge approaches (AI, microbiome science, advanced imaging)
• Collaborative: Multi-institution partnerships (e.g., Edinburgh grant involves teams from Stavanger, Johns Hopkins, Dundee)
• Patient impact: Clear pathway to understanding, preventing, diagnosing or treating neurodegenerative diseases
• Strategic alignment: Projects align with Trust's core focus on parkinsonian disorders and dementia
• Scale: Projects are substantial, multi-year research programmes requiring significant investment

Recent Funding Patterns:

The 2025 UCL award for the “Reta Lila Weston BRAIN” platform demonstrates the Trust's interest in infrastructure that enables multiple research projects - analyzing data from 2,500 brain and spinal cord tissue samples to support numerous research teams.

Key Takeaways for Grant Writers

• No public applications: This is a private trust operating through invitation and pre-existing relationships - you cannot submit an unsolicited application
• Strategic, high-value grants: The Trust makes large grants (£750,000+) for major research initiatives, not small project grants
• Focus on elite institutions: Documented funding goes to leading UK neurology research centres (UCL Queen Square Institute, University of Edinburgh, National Hospital for Neurology)
• Long-term relationships: UCL partnership spans 50+ years; the Trust values sustained partnerships over one-off projects
• Thematic initiatives: The Trust occasionally launches specific funding calls on priority themes (like the 2016 Microbiome initiative) which may be announced through partner institutions
• Neurodegeneration only: Exclusively funds research on neurodegenerative diseases, particularly parkinsonian disorders and dementia
• Translational research valued: Funded projects show clear pathways from laboratory research to clinical benefit

Similar Funders

These funders have a similar focus and geographic reach:

• The Anton Jurgens Charitable Trust
• Bbc Children In Need
• Wessex Medical Trust
• Nuclear Community Charity Fund
• The Charles Hayward Foundation
• Lta Tennis Foundation
• Alzheimer's Research Uk
• The Frances And Augustus Newman Foundation
• Wooden Spoon Society
• John Horniman's Children's Trust

References

• UK Charity Commission Register, Charity No. 256279: https://register-of-charities.charitycommission.gov.uk/en/charity-search/-/charity-details/256279
• UCL News: “UCL awarded £5.1m to unlock neurodegenerative secrets with AI”: https://www.ucl.ac.uk/news/2025/may/ucl-awarded-ps51m-unlock-neurodegenerative-secrets-ai
• Edinburgh Neuroscience: "Research into effect of probiotic brings together fundamental and clinical Parkinson's research" (2021): https://www.edinburghneuroscience.ed.ac.uk/news/research-effect-probiotic-brings-together-fundamental-and-clinical-parkinsons-research
• UCL Institute of Neurology: “Changes to gut bacteria could hold key to slowing down Motor Neurone Disease”: https://www.ucl.ac.uk/ion/news/2017/mar/changes-gut-bacteria-could-hold-key-slowing-down-motor-neurone-disease
• UCL Queen Square Institute of Neurology: Reta Lila Weston Institute of Neurological Studies information: https://www.ucl.ac.uk/ion/research/research-centres/reta-lila-weston-institute-neurological-studies